FDA Orange Book · active-ingredient family
Glycerol phenylbutyrate
Glycerol phenylbutyrate is approved as 1 brand and 6 generic applications in the FDA Orange Book, with their therapeutic-equivalence codes, listed patents, and marketing exclusivity.
Reference-listed drug:RAVICTI · NDA 203284
1
Brand (NDA)
6
Generics (ANDA)
15
Listed patents
1
Exclusivity periods
Brand (NDA) products · liquid
| Product | Applicant | Application | TE | Approved | |
|---|---|---|---|---|---|
| RAVICTIRLD | HORIZON THERAP US | NDA 203284 | AA | Feb 01, 2013 |
Generic (ANDA) products (6)
| Product | Applicant | Application | TE | Approved | |
|---|---|---|---|---|---|
| GLYCEROL PHENYLBUTYRATE | LUPIN | ANDA 207694 | AA | Apr 30, 2026 | |
| GLYCEROL PHENYLBUTYRATE | NAVINTA LLC | ANDA 220568 | AA | Apr 23, 2026 | |
| GLYCEROL PHENYLBUTYRATE | AUROBINDO PHARMA | ANDA 220313 | AA | Apr 15, 2026 | |
| GLYCEROL PHENYLBUTYRATE | MSN | ANDA 219540 | AA | Apr 15, 2026 | |
| GLYCEROL PHENYLBUTYRATE | TEVA PHARMS INC | ANDA 218738 | AA | Apr 15, 2026 | |
| GLYCEROL PHENYLBUTYRATE | PH HEALTH | ANDA 205742 | AA | Dec 02, 2021 |
Marketing exclusivity (1)
- PCPatent-challenge (180-day generic) exclusivity
Apr 15, 2026
2 mo ago
Listed patents (15)
| Patent | Expires | In | Type |
|---|---|---|---|
| 9962359 | Sep 22, 2030 | in 4 yr 4 mo | U-1816 |
| 9561197 | Sep 22, 2030 | in 4 yr 4 mo | U-1383 |
| 10183003 | Sep 22, 2030 | in 4 yr 4 mo | U-1816 |
| 10183002 | Sep 22, 2030 | in 4 yr 4 mo | U-1816 |
| 10183004 | Sep 22, 2030 | in 4 yr 4 mo | U-1816 |
| 8642012 | Sep 22, 2030 | in 4 yr 4 mo | U-1383 |
| 10045959 | Sep 22, 2030 | in 4 yr 4 mo | U-1816 |
| 9999608 | Sep 22, 2030 | in 4 yr 4 mo | U-1816 |
| 9326966 | Sep 22, 2030 | in 4 yr 4 mo | U-1816 |
| 10668040 | Sep 22, 2030 | in 4 yr 4 mo | U-1816 |
| 10183005 | Sep 22, 2030 | in 4 yr 4 mo | U-1816 |
| 10183006 | Sep 22, 2030 | in 4 yr 4 mo | U-1816 |
| 10045958 | Sep 22, 2030 | in 4 yr 4 mo | U-1816 |
| 9254278 | Sep 22, 2030 | in 4 yr 4 mo | U-1816 |
| 8404215 | Mar 09, 2032 | in 5 yr 10 mo | U-1383Delisted |
Glycerol phenylbutyrate — frequently asked questions
Generics, reference-listed drug, patents, and exclusivity for this active ingredient, from the FDA Orange Book.

